BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 8711101)

  • 21. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
    Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
    J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV--Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(33):688-91. PubMed ID: 9733415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital--Atlanta, Georgia, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1245-8. PubMed ID: 14704648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].
    Postma MJ; van den Hoek JA; Beck EJ; Heeg B; Jager JC; Coutinho RA
    Ned Tijdschr Geneeskd; 2000 Apr; 144(16):749-54. PubMed ID: 10812443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
    J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the cost of preventing AIDS transmission from mothers to children: an effect analysis].
    Guo JL; Wang YM; Liang SY; Wang Z; Hu XY; Zhang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Mar; 28(3):258-60. PubMed ID: 17649659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in pediatric HIV.
    Menard J; Tucker NC; Darville T
    J Ark Med Soc; 1995 Sep; 92(4):165-8. PubMed ID: 7592235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV testing among pregnant women--United States and Canada, 1998-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(45):1013-6. PubMed ID: 12458916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a regional pilot program to prevent mother-infant HIV transmission--Thailand, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(28):599-603. PubMed ID: 11476529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine prenatal screening for HIV in a low-prevalence setting.
    Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
    CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
    Rely K; Bertozzi SM; Avila-Figueroa C; Guijarro MT
    Health Policy Plan; 2003 Sep; 18(3):290-8. PubMed ID: 12917270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of an HIV voluntary counseling and testing program for pregnant women in Georgia.
    Butsashvili M; Preble E; Kamkamidze G; Robinson J; Chubinishvili O; Sukhiashvili R
    AIDS Care; 2008 Oct; 20(9):1125-7. PubMed ID: 18825518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women(1).
    Chen KT; Sell RL; Tuomala RE
    Obstet Gynecol; 2001 Feb; 97(2):161-8. PubMed ID: 11165575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of HIV infection in drug abusers: a cost analysis.
    Gorsky RD; MacGowan RJ; Swanson NM; DelGado BP
    Prev Med; 1995 Jan; 24(1):3-8. PubMed ID: 7740013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of screening health care workers for HIV.
    Chavey WE; Cantor SB; Clover RD; Reinarz JA; Spann SJ
    J Fam Pract; 1994 Mar; 38(3):249-57. PubMed ID: 8126405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
    Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
    Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
    Myers ER; Thompson JW; Simpson K
    Obstet Gynecol; 1998 Feb; 91(2):174-81. PubMed ID: 9469271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.